<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Antibiotic & Infection Guide</title>
<style>
body {
  font-family: Arial, sans-serif;
  margin: 0;
  padding: 0;
  display: flex;
}
header {
  position: fixed;
  top: 0;
  width: 100%;
  background-color: #004080;
  color: white;
  z-index: 1000;
  display: flex;
  align-items: center;
  padding: 0.5em;
}
header img {
  height: 40px;
  margin-right: 10px;
}
header h1 {
  margin: 0;
  font-size: 1.5em;
}
header input[type="text"] {
  margin-left: auto;
  padding: 0.25em;
  font-size: 1em;
}
#sidebar {
  width: 250px;
  background-color: #f0f0f0;
  padding-top: 70px;
  height: 100vh;
  position: fixed;
  overflow-y: auto;
}
#sidebar a {
  display: block;
  padding: 10px;
  text-decoration: none;
  color: #004080;
}
#sidebar a:hover {
  background-color: #ddd;
}
main {
  margin-left: 260px;
  padding: 70px 20px 20px 20px;
}
.collapsible {
  background-color: #eee;
  color: #004080;
  cursor: pointer;
  padding: 10px;
  width: 100%;
  border: none;
  text-align: left;
  outline: none;
  margin-top: 5px;
}
.collapsible:after {
  content: '+';
  float: right;
}
.collapsible.active:after {
  content: "-";
}
.content {
  display: none;
  padding: 0 15px;
  overflow: hidden;
}
table {
  border-collapse: collapse;
  width: 100%;
  margin-bottom: 1em;
}
th, td {
  border: 1px solid #ccc;
  padding: 8px;
  text-align: left;
}
th {
  background-color: #004080;
  color: white;
}
ul {
  padding-left: 20px;
}
.calculator {
  border: 1px solid #ccc;
  padding: 10px;
  margin: 10px 0;
}
</style>
</head>
<body>
<header>
  <img src="mutant-icon.png" alt="Logo">
  <h1>Antibiotic & Infection Guide</h1>
  <input type="text" id="searchBar" placeholder="Search pathogens...">
</header>

<div id="sidebar">
  <a href="#homepage">Home</a>
  <a href="#empiric-therapy">Empiric Therapy</a>
  <a href="#anatomic-infections">Infections by Anatomic Site</a>
  <a href="#sepsis">Sepsis</a>
  <a href="#pathogen-guidance">Pathogen-Based Guidance</a>
  <a href="#pathogen-overview">Pathogen Overview</a>
  <a href="#antibiotic-classes">Antibiotic Classes / Escalation</a>
  <a href="#fungal-infections">Fungal Infections</a>
  <a href="#viral-infections">Viral Infections</a>
  <a href="#tickborne-illnesses">Tickborne Illnesses</a>
  <a href="#viral-encephalopathies">Viral Encephalopathies</a>
  <a href="#calculators">Calculators</a>
  <a href="#references">References</a>
</div>

<main>
<section id="homepage">
<h2>Antibiotic & Infection Guide</h2>
<p>Use the sidebar to navigate. Expand each section for detailed dosing, duration, organism-specific notes, and references.</p>
<p><strong>Basic ID Approach Tips:</strong></p>
<ul>
  <li>Assess severity, comorbidities, and immunocompetence.</li>
  <li>Obtain cultures prior to starting antibiotics if possible.</li>
  <li>Start empiric therapy based on likely pathogens and infection site.</li>
  <li>Adjust antibiotics according to culture results and susceptibilities.</li>
  <li>Consider source control: drain abscesses, remove infected devices.</li>
</ul>
</section>

<section id="empiric-therapy">
<h2>Empiric Therapy</h2>
<!-- Gram-Positive Cocci -->
<button class="collapsible">Gram-Positive Cocci</button>
<div class="content">
<table>
<tr><th>Organism</th><th>Empiric Therapy</th><th>Dose / Route</th><th>Duration</th></tr>
<tr><td>Staphylococcus aureus (MSSA)</td><td>Nafcillin / Oxacillin</td><td>2 g IV q4h</td><td>7–14 days</td></tr>
<tr><td>MRSA</td><td>Vancomycin</td><td>15 mg/kg IV q12h</td><td>7–21 days</td></tr>
<tr><td>Streptococcus spp.</td><td>Penicillin G / Ceftriaxone</td><td>4 MU IV q4h / 2 g IV q24h</td><td>10–14 days</td></tr>
<tr><td>Enterococcus spp.</td><td>Ampicillin / Vancomycin</td><td>2 g IV q4h / 15 mg/kg IV q12h</td><td>14–21 days</td></tr>
</table>
</div>
<!-- Gram-Negative Rods -->
<button class="collapsible">Gram-Negative Rods</button>
<div class="content">
<table>
<tr><th>Organism</th><th>Empiric Therapy</th><th>Dose / Route</th><th>Duration</th></tr>
<tr><td>E. coli</td><td>Ceftriaxone</td><td>2 g IV q24h</td><td>7–10 days</td></tr>
<tr><td>Klebsiella spp.</td><td>Ceftriaxone / Piperacillin-tazobactam</td><td>2 g IV q24h / 4.5 g IV q6–8h</td><td>7–14 days</td></tr>
<tr><td>Pseudomonas aeruginosa</td><td>Piperacillin-tazobactam / Ceftazidime</td><td>4.5 g IV q6–8h / 2 g IV q8h</td><td>10–14 days</td></tr>
<tr><td>Burkholderia spp.</td><td>Ceftazidime / Meropenem</td><td>2 g IV q8h / 1 g IV q8h</td><td>10–14 days</td></tr>
</table>
</div>
<!-- Anaerobes -->
<button class="collapsible">Anaerobes</button>
<div class="content">
<table>
<tr><th>Organism</th><th>Empiric Therapy</th><th>Dose / Route</th><th>Duration</th></tr>
<tr><td>Bacteroides fragilis</td><td>Metronidazole / Piperacillin-tazobactam</td><td>500 mg IV q8h / 4.5 g IV q6–8h</td><td>7–14 days</td></tr>
<tr><td>Clostridium spp.</td><td>Oral Vancomycin / Metronidazole</td><td>125 mg PO q6h / 500 mg IV q8h</td><td>10–14 days</td></tr>
<tr><td>Actinomyces spp.</td><td>Penicillin G</td><td>4 MU IV q4h</td><td>6–12 months</td></tr>
</table>
</div>
<!-- Intracellular / Fastidious -->
<button class="collapsible">Intracellular / Fastidious Pathogens</button>
<div class="content">
<table>
<tr><th>Organism</th><th>Empiric Therapy</th><th>Dose / Route</th><th>Duration</th></tr>
<tr><td>Chlamydia trachomatis</td><td>Doxycycline</td><td>100 mg PO q12h</td><td>7 days</td></tr>
<tr><td>Legionella pneumophila</td><td>Azithromycin / Levofloxacin</td><td>500 mg IV/PO daily / 750 mg IV/PO daily</td><td>7–10 days</td></tr>
<tr><td>Mycobacterium spp. (non-TB)</td><td>Macrolide-based combination</td><td>Varies by species</td><td>Weeks–Months</td></tr>
<tr><td>Nocardia spp.</td><td>Trimethoprim-sulfamethoxazole</td><td>15 mg/kg/day IV divided q6–8h</td><td>6–12 months</td></tr>
</table>
</div>
</section>

<section id="anatomic-infections">
<h2>Infections by Anatomic Site</h2>
<!-- Head & Neck -->
<button class="collapsible">Head & Neck</button>
<div class="content">
<ul>
<li>Sinusitis: Amoxicillin-clavulanate 875/125 mg PO BID 5–7d</li>
<li>Mastoiditis: Ceftriaxone 2 g IV q24h 10–14d</li>
<li>Otitis media: Amoxicillin 500 mg PO q8h 5–7d</li>
</ul>
</div>
<!-- Respiratory -->
<button class="collapsible">Respiratory Tract</button>
<div class="content">
<ul>
<li>CAP: Ceftriaxone 2 g IV q24h + Azithromycin 500 mg IV/PO day 1 then 250 mg daily 5–7d</li>
<li>HAP/VAP: Piperacillin-tazobactam 4.5 g IV q6–8h 7–14d, add Vancomycin for MRSA risk</li>
</ul>
</div>
<!-- Urinary -->
<button class="collapsible">Urinary Tract / Pyelonephritis</button>
<div class="content">
<ul>
<li>Uncomplicated UTI: Nitrofurantoin 100 mg PO BID 5–7d</li>
<li>Pyelonephritis: Ciprofloxacin 500 mg PO q12h 7–10d</li>
</ul>
</div>
<!-- Gastrointestinal -->
<button class="collapsible">Gastrointestinal / Intra-abdominal</button>
<div class="content">
<ul>
<li>Diverticulitis: Ciprofloxacin 500 mg PO q12h + Metronidazole 500 mg PO q8h 7–10d</li>
<li>Appendicitis post-op prophylaxis: Cefazolin 2 g IV pre-op single dose</li>
</ul>
</div>
<!-- Skin & Soft Tissue -->
<button class="collapsible">Skin & Soft Tissue</button>
<div class="content">
<ul>
<li>Cellulitis: Cefazolin 2 g IV q8h 7–10d</li>
<li>Necrotizing fasciitis: Broad-spectrum (Meropenem + Vancomycin + Clindamycin) 14–21d</li>
</ul>
</div>
<!-- Bone & Joint -->
<button class="collapsible">Bone & Joint</button>
<div class="content">
<ul>
<li>Osteomyelitis: Ceftriaxone 2 g IV q24h 6 weeks</li>
<li>Septic arthritis: Vancomycin + Ceftriaxone 2–4 weeks</li>
</ul>
</div>
</section>

<section id="sepsis">
<h2>Sepsis</h2>
<button class="collapsible">Quick Reference (Immediate Actions)</button>
<div class="content">
<ul>
<li>Obtain cultures before antibiotics if possible, but do not delay therapy.</li>
<li>Start broad-spectrum antibiotics within 1 hour.</li>
<li>Fluid resuscitation: 30 mL/kg crystalloid bolus if hypotensive or lactate ≥4 mmol/L.</li>
<li>Vasopressors to maintain MAP ≥65 mmHg if hypotension persists.</li>
<li>Measure lactate; repeat if initial >2 mmol/L.</li>
</ul>
</div>
<button class="collapsible">Detailed Approach / Mechanisms</button>
<div class="content">
<ul>
<li>Sepsis is life-threatening organ dysfunction caused by dysregulated host response to infection.</li>
<li>Monitor SOFA/qSOFA scores to guide severity and prognosis.</li>
<li>Address source control: remove infected lines, drain abscesses, debride necrotic tissue.</li>
<li>Adjust antibiotic regimen based on culture and sensitivities.</li>
<li>Monitor for complications: DIC, ARDS, AKI, multi-organ failure.</li>
</ul>
</div>
</section>

<section id="pathogen-guidance">
<h2>Pathogen-Based Guidance</h2>
<button class="collapsible">Gram-Positive Cocci</button>
<div class="content">
<ul>
<li>Staphylococcus aureus: MSSA (Nafcillin), MRSA (Vancomycin)</li>
<li>Streptococcus spp.: Penicillin, Ceftriaxone</li>
<li>Enterococcus spp.: Ampicillin or Vancomycin</li>
</ul>
</div>

<button class="collapsible">Gram-Negative Rods</button>
<div class="content">
<ul>
<li>E. coli, Klebsiella: Ceftriaxone, Piperacillin-tazobactam</li>
<li>Pseudomonas: Piperacillin-tazobactam, Ceftazidime</li>
<li>Burkholderia: Ceftazidime, Meropenem</li>
</ul>
</div>

<button class="collapsible">Anaerobes</button>
<div class="content">
<ul>
<li>Bacteroides fragilis: Metronidazole or Piperacillin-tazobactam</li>
<li>Clostridium spp.: Oral Vancomycin or Metronidazole</li>
<li>Actinomyces: Penicillin G</li>
</ul>
</div>

<button class="collapsible">Intracellular / Fastidious</button>
<div class="content">
<ul>
<li>Chlamydia, Legionella, Mycoplasma: Macrolides or Tetracyclines</li>
<li>Nocardia: TMP-SMX</li>
</ul>
</div>
</section>

<section id="pathogen-overview">
<h2>Pathogen Overview</h2>
<!-- E. coli -->
<button class="collapsible pathogen">E. coli</button>
<div class="content">
<ul>
<li>Gram-negative rod, facultative anaerobe</li>
<li>Common cause of UTI, bacteremia, intra-abdominal infections</li>
<li>ESBL resistance increasing globally</li>
<li>Pathogenesis: adhesins, endotoxins</li>
<li>Risk factors: catheterization, hospitalization, immunosuppression</li>
</ul>
</div>
<!-- Klebsiella spp. -->
<button class="collapsible pathogen">Klebsiella spp.</button>
<div class="content">
<ul>
<li>Gram-negative rod</li>
<li>Causes pneumonia, UTIs, bacteremia</li>
<li>ESBL and carbapenem resistance emerging</li>
<li>Virulence: capsule, siderophores</li>
<li>Risk factors: diabetes, chronic lung disease</li>
</ul>
</div>
<!-- Pseudomonas -->
<button class="collapsible pathogen">Pseudomonas aeruginosa</button>
<div class="content">
<ul>
<li>Gram-negative rod, non-fermenter</li>
<li>Common in HAP, VAP, wound infections</li>
<li>Resistance: efflux pumps, beta-lactamases</li>
<li>Biofilm formation contributes to chronic infections</li>
</ul>
</div>
<!-- Burkholderia -->
<button class="collapsible pathogen">Burkholderia spp.</button>
<div class="content">
<ul>
<li>Gram-negative rod, non-fermenter</li>
<li>Opportunistic infections in immunocompromised hosts</li>
<li>Resistant to many beta-lactams and aminoglycosides</li>
<li>Treatment: Ceftazidime, Meropenem</li>
</ul>
</div>
<!-- Bacteroides -->
<button class="collapsible pathogen">Bacteroides fragilis</button>
<div class="content">
<ul>
<li>Anaerobic Gram-negative rod</li>
<li>Common in intra-abdominal infections, abscesses</li>
<li>Treatment: Metronidazole, Piperacillin-tazobactam</li>
</ul>
</div>
<!-- Clostridium -->
<button class="collapsible pathogen">Clostridium spp.</button>
<div class="content">
<ul>
<li>Gram-positive anaerobe</li>
<li>Includes C. difficile, C. perfringens</li>
<li>Treatment: Oral Vancomycin, Metronidazole</li>
</ul>
</div>
<!-- Actinomyces -->
<button class="collapsible pathogen">Actinomyces spp.</button>
<div class="content">
<ul>
<li>Gram-positive anaerobic rod</li>
<li>Causes chronic abscesses, often cervicofacial</li>
<li>Treatment: Penicillin G, long-term therapy</li>
</ul>
</div>
<!-- Mycobacterium -->
<button class="collapsible pathogen">Mycobacterium spp. (non-TB)</button>
<div class="content">
<ul>
<li>Slow-growing, intracellular</li>
<li>Causes opportunistic infections, pulmonary disease</li>
<li>Treatment: Macrolide-based combination therapy</li>
</ul>
</div>
<!-- Nocardia -->
<button class="collapsible pathogen">Nocardia spp.</button>
<div class="content">
<ul>
<li>Gram-positive, weakly acid-fast branching filamentous bacteria</li>
<li>Causes pulmonary, CNS, cutaneous infections</li>
<li>Treatment: TMP-SMX for 6–12 months</li>
</ul>
</div>
<!-- Intracellular Pathogens -->
<button class="collapsible pathogen">Intracellular / Fastidious Pathogens</button>
<div class="content">
<ul>
<li>Chlamydia spp.: Doxycycline or Macrolides</li>
<li>Legionella pneumophila: Levofloxacin or Azithromycin</li>
<li>Mycoplasma pneumoniae: Macrolides or Tetracyclines</li>
</ul>
</div>
<!-- Fungi -->
<button class="collapsible pathogen">Fungi</button>
<div class="content">
<ul>
<li>Candida spp.: Fluconazole</li>
<li>Aspergillus spp.: Voriconazole</li>
<li>Cryptococcus spp.: Amphotericin B + Flucytosine</li>
</ul>
</div>
<!-- Viruses -->
<button class="collapsible pathogen">Viruses</button>
<div class="content">
<ul>
<li>Influenza A/B: Oseltamivir</li>
<li>HSV 1/2: Acyclovir</li>
<li>CMV: Ganciclovir</li>
</ul>
</div>

<!-- Tickborne Illnesses -->
<section id="tickborne-illnesses">
<h2>Tickborne Illnesses</h2>
<button class="collapsible pathogen">Borrelia burgdorferi (Lyme disease)</button>
<div class="content">
<ul>
<li>Gram-negative spirochete</li>
<li>Early: erythema migrans, fever, arthralgia</li>
<li>Treatment: Doxycycline 100 mg PO BID 10–21 days</li>
</ul>
</div>
<button class="collapsible pathogen">Anaplasma phagocytophilum (Anaplasmosis)</button>
<div class="content">
<ul>
<li>Intracellular Gram-negative bacterium</li>
<li>Symptoms: fever, malaise, cytopenias</li>
<li>Treatment: Doxycycline 100 mg PO/IV BID 10–14 days</li>
</ul>
</div>
<button class="collapsible pathogen">Babesia microti (Babesiosis)</button>
<div class="content">
<ul>
<li>Intraerythrocytic protozoa</li>
<li>Symptoms: hemolysis, fever, fatigue</li>
<li>Treatment: Atovaquone + Azithromycin for 7–10 days</li>
</ul>
</div>
<button class="collapsible pathogen">Rickettsia rickettsii (Rocky Mountain spotted fever)</button>
<div class="content">
<ul>
<li>Obligate intracellular Gram-negative bacterium</li>
<li>Symptoms: fever, rash, headache</li>
<li>Treatment: Doxycycline 100 mg PO/IV BID 7–14 days</li>
</ul>
</div>
</section>

<!-- Viral Encephalopathies -->
<section id="viral-encephalopathies">
<h2>Viral Encephalopathies</h2>
<button class="collapsible pathogen">West Nile Virus</button>
<div class="content">
<ul>
<li>Flavivirus transmitted by mosquitoes</li>
<li>Symptoms: fever, headache, neuroinvasive disease in some</li>
<li>Treatment: Supportive care, no antiviral approved</li>
</ul>
</div>
<button class="collapsible pathogen">Eastern Equine Encephalitis</button>
<div class="content">
<ul>
<li>Alphavirus transmitted by mosquitoes</li>
<li>Symptoms: high fever, severe neurological disease</li>
<li>Treatment: Supportive care, ICU-level management</li>
</ul>
</div>
<button class="collapsible pathogen">Japanese Encephalitis Virus</button>
<div class="content">
<ul>
<li>Flavivirus transmitted by Culex mosquitoes</li>
<li>Symptoms: fever, meningitis/encephalitis</li>
<li>Treatment: Supportive care, vaccination preventive</li>
</ul>
</div>
</section>

<section id="antibiotic-classes">
<h2>Antibiotic Classes / Escalation</h2>
<table>
<tr><th>Class</th><th>Target</th><th>Common Agents</th><th>Alternatives</th><th>Notes</th><th>Typical Duration</th></tr>
<tr><td>Beta-lactams</td><td>Gram ±, some anaerobes</td><td>Penicillins, Cephalosporins</td><td>Carbapenems</td><td>Time-dependent killing</td><td>7–14 days</td></tr>
<tr><td>Macrolides</td><td>Atypical, Gram +</td><td>Azithromycin, Clarithromycin</td><td>Erythromycin</td><td>Good tissue penetration</td><td>5–10 days</td></tr>
<tr><td>Tetracyclines</td><td>Intracellular, some Gram ±</td><td>Doxycycline</td><td>Minocycline</td><td>Avoid in pregnancy</td><td>7–14 days</td></tr>
<tr><td>Fluoroquinolones</td><td>Gram ±, Pseudomonas</td><td>Levofloxacin, Ciprofloxacin</td><td>Moxifloxacin</td><td>Watch QT prolongation</td><td>7–14 days</td></tr>
<tr><td>Glycopeptides</td><td>Gram +, MRSA</td><td>Vancomycin</td><td>Teicoplanin</td><td>Monitor troughs</td><td>7–21 days</td></tr>
</table>
</section>

<section id="fungal-infections">
<h2>Fungal Infections</h2>
<table>
<tr><th>Organism</th><th>Drug</th><th>Dose / Route</th><th>Duration</th></tr>
<tr><td>Candida spp.</td><td>Fluconazole</td><td>800 mg PO/IV day 1, then 400 mg daily</td><td>14 days after negative cultures</td></tr>
<tr><td>Aspergillus spp.</td><td>Voriconazole</td><td>6 mg/kg IV q12h ×2 doses, then 4 mg/kg IV q12h</td><td>6–12 weeks</td></tr>
<tr><td>Cryptococcus spp.</td><td>Amphotericin B + Flucytosine</td><td>Varies by regimen</td><td>2–6 weeks</td></tr>
</table>
</section>

<section id="viral-infections">
<h2>Viral Infections</h2>
<table>
<tr><th>Organism</th><th>Drug</th><th>Dose / Route</th><th>Duration</th></tr>
<tr><td>Influenza A/B</td><td>Oseltamivir</td><td>75 mg PO BID</td><td>5 days</td></tr>
<tr><td>HSV 1/2</td><td>Acyclovir</td><td>400 mg PO TID or 5 mg/kg IV q8h</td><td>7–14 days</td></tr>
<tr><td>CMV</td><td>Ganciclovir</td><td>5 mg/kg IV q12h</td><td>14–21 days</td></tr>
</table>
</section>

<section id="tickborne-illnesses"></section>
<section id="viral-encephalopathies"></section>

<section id="calculators">
<h2>Calculators</h2>
<div class="calculator">
<h3>CrCl (Cockcroft-Gault)</h3>
<label>Weight (kg): <input type="number" id="wt"></label>
<label>Age (yr): <input type="number" id="age"></label>
<label>Serum Cr (mg/dL): <input type="number" id="cr"></label>
<label>Female? <input type="checkbox" id="female"></label>
<button onclick="calcCrCl()">Calculate</button>
<p id="crclResult"></p>
</div>

<div class="calculator">
<h3>SOFA Score</h3>
<p>Input organ-specific values to calculate score (simplified placeholder for interactive use)</p>
</div>
</section>

<section id="references">
<h2>References</h2>
<ul>
<li><a href="https://www.idsociety.org/practice-guideline/antimicrobial-therapy-guidelines/" target="_blank" rel="noopener noreferrer">IDSA Guidelines</a></li>
<li><a href="https://www.nejm.org/browse/specialty/infectious-disease/" target="_blank" rel="noopener noreferrer">NEJM</a></li>
<li><a href="https://jamanetwork.com/" target="_blank" rel="noopener noreferrer">JAMA</a></li>
<li>Harrison’s Principles of Internal Medicine, 21st Edition</li>
</ul>
</section>

<script>
document.querySelectorAll('.collapsible').forEach(button => {
  button.addEventListener('click', () => {
    button.classList.toggle('active');
    const content = button.nextElementSibling;
    content.style.display = (content.style.display === 'block') ? 'none' : 'block';
  });
});

function calcCrCl() {
  const wt = parseFloat(document.getElementById('wt').value);
  const age = parseFloat(document.getElementById('age').value);
  const cr = parseFloat(document.getElementById('cr').value);
  const female = document.getElementById('female').checked;
  if (!wt || !age || !cr) {
    document.getElementById('crclResult').textContent = 'Enter all values.';
    return;
  }
  let crcl = ((140 - age) * wt) / (72 * cr);
  if (female) crcl *= 0.85;
  document.getElementById('crclResult').textContent = `CrCl: ${crcl.toFixed(1)} mL/min`;
}

// Pathogen search/filter
document.getElementById('searchBar').addEventListener('input', function() {
  const query = this.value.toLowerCase();
  document.querySelectorAll('.collapsible.pathogen').forEach(btn => {
    const text = btn.textContent.toLowerCase();
    btn.style.display = text.includes(query) ? 'block' : 'none';
    if (btn.nextElementSibling) btn.nextElementSibling.style.display = 'none';
  });
});
</script>
</body>
</html>
